|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61P 1/00 | (2006.01) |
| (11) | Number of the document | 3430043 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17710748.9 |
| Date of filing the European patent application | 2017-03-16 | |
| (97) | Date of publication of the European application | 2019-01-23 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-30 |
| (46) | Date of publication of the claims translation | 2023-12-27 |
| (86) | Number | PCT/EP2017/056237 |
| Date | 2017-03-16 |
| (87) | Number | WO 2017/158092 |
| Date | 2017-09-21 |
| (30) | Number | Date | Country code |
| 16160907 | 2016-03-17 | EP |
| (72) |
GUNDE, Tea , CH
MEYER, Sebastian , CH
FURRER, Esther Maria , CH
|
| (73) |
Tillotts Pharma AG ,
Baslerstrasse 15, 4310 Rheinfelden,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-TNF alfa antikūnai ir funkciniai jų fragmentai |
| ANTI-TNFALPHA-ANTIBODIES AND FUNCTIONAL FRAGMENTS THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-03-05 | 10 | 231.00 EUR |
| 2027-03-16 |